Thymulin dosage

Thymulin dosage guidance

A historical intravenous synthetic FTS schedule uses 10 mcg/kg every 3 days; a complete course length is not specified. Separate nonathymulin regimens compared 1, 5 and 10 mg per day in rheumatoid arthritis, but the abstract does not specify their administration route. These historical preparations do not define a current zinc-thymulin vial protocol.[1][2]

Thymulin is a nine-amino-acid hormone whose activity depends on zinc binding. Zinc supplementation, unbound FTS and zinc-bound thymulin are different exposures.[3][4][5][6]

Frequency and timing

A meal, exercise or bedtime anchor is not established for administered human zinc-thymulin.[3][1]

Cycle length and breaks

A standard course length for Thymulin has not been established. A standard break interval between courses is not established.

Approval and product quality

Thymulin is not an FDA-approved drug.[8]

Side effects and long-term safety

Dose-dependent immune effects, repeated exposure and interactions remain uncertain for a current zinc-bound preparation. Human side-effect rates and long-term safety have not been established.[1][3][7]

Route-specific dosing limits

Zinc-bound thymulin, unbound FTS, zinc supplements and gene-transfer preparations are different exposures. Their doses and safety information cannot be transferred between preparations.[3][1][7]